Scientific Opinion on the substantiation of health claims related to soy isoflavones and maintenance of bone mineral density (ID 1655) and reduction of vasomotor symptoms associated with menopause (ID 1654, 1704, 2140, 3093, 3154, 3590) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

被引：13

作者：

Agostoni, Carlo ^{[1
]}

Bresson, Jean-Louis ^{[1
]}

Fairweather-Tait, Susan ^{[1
]}

Flynn, Albert ^{[1
]}

Golly, Ines ^{[1
]}

Korhonen, Hannu ^{[1
]}

Lagiou, Pagona ^{[1
]}

Lovik, Martinus ^{[1
]}

Marchelli, Rosangela ^{[1
]}

Martin, Ambroise ^{[1
]}

Moseley, Bevan ^{[1
]}

Neuhauser-Berthold, Monika ^{[1
]}

Przyrembel, Hildegard ^{[1
]}

Salminen, Seppo ^{[1
]}

Sanz, Yolanda ^{[1
]}

Strain, Sean ^{[1
]}

Strobel, Stephan ^{[1
]}

Tetens, Inge ^{[1
]}

Tome, Daniel ^{[1
]}

van Loveren, Hendrik ^{[1
]}

Verhagen, Hans ^{[1
]}

机构：

[1] EFSA, Parma, Italy

来源：

EFSA JOURNAL | 2012年 / 10卷 / 08期

关键词：

Soy isoflavones; bone mineral density; vasomotor symptoms; menopause; health claims;

D O I：

10.2903/j.efsa.2012.2847

中图分类号：

TS2 [食品工业];

学科分类号：

0832 ;

摘要：

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a scientific opinion on health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 in the framework of further assessment related to soy isoflavones and maintenance of bone mineral density and reduction of vasomotor symptoms associated with menopause. The food constituent that is the subject of the claim, soy isoflavones, is sufficiently characterised. The claimed effects, maintenance of bone mineral density and reduction of vasomotor symptoms associated with menopause, which are eligible for further assessment, are beneficial physiological effects. The proposed target populations are peri-and/or postmenopausal women. On the basis of the data presented, the Panel concludes that the evidence provided is insufficient to establish a cause and effect relationship between the consumption of soy isoflavones and maintenance of bone mineral density, and between the consumption of soy isoflavones and reduction of vasomotor symptoms associated with menopause. (C) European Food Safety Authority, 2012

引用

页数：36

共 84 条

[81] Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial [J].

Wu, J ;

Oka, J ;

Higuchi, M ;

Tabata, I ;

Toda, T ;

Fujioka, M ;

Fuku, N ;

Teramoto, T ;

Okuhira, T ;

Ueno, T ;

Uchiyama, S ;

Urata, K ;

Yamada, K ;

Ishimi, Y .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (04) :423-433

[82]

XIN Y, 2006, CHIN J OSTEOPOROS, V12, P149

[83] Soy isoflavones attenuate bone loss in early postmenopausal Chinese women - A single-blind randomized, placebo-controlled trial [J].

Ye, Yan-Bin ;

Tang, Xing-Yi ;

Verbruggen, Marian A. ;

Su, Yi-Xiang .

EUROPEAN JOURNAL OF NUTRITION, 2006, 45 (06) :327-334

[84]

YI YB, 2004, ACTA NUTR SINICA, V26, P49

← 1 2 3 4 5 6 7 8 9 →